IL33 and chronic obstructive pulmonary disease: We have previously reported an increased level of oxidative stress in HBECs of COPD patients compared to those in healthy subjects [51] and, therefore, it could be thought that NAC treatment decreased the increased level of oxidative stress in the HBECs of COPD patients, which affects the expression of IL-33.